Ovarian damage from chemotherapy and current approaches to its protection
N Spears, F Lopes, A Stefansdottir… - Human reproduction …, 2019 - academic.oup.com
Background Anti-cancer therapy is often a cause of premature ovarian insufficiency and
infertility since the ovarian follicle reserve is extremely sensitive to the effects of …
infertility since the ovarian follicle reserve is extremely sensitive to the effects of …
Sex and gender influences on cancer immunotherapy response
A Irelli, MM Sirufo, C D'Ugo, L Ginaldi, M De Martinis - Biomedicines, 2020 - mdpi.com
The global burden of cancer is growing and a wide disparity in the incidence, malignancy
and mortality of different types of cancer between each sex has been demonstrated. The sex …
and mortality of different types of cancer between each sex has been demonstrated. The sex …
Decrease post-transplant relapse using donor-derived expanded NK-cells
In this phase I/II clinical trial, we investigated the safety and efficacy of high doses of mb-IL21
ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid …
ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid …
Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a …
N Gagelmann, A Bacigalupo, A Rambaldi… - JAMA …, 2019 - jamanetwork.com
Importance Use of haploidentical (HAPLO) stem cell transplantation with posttransplant
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
Treatment of allosensitized patients receiving allogeneic transplantation
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments …
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments …
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide
SR McCurdy, L Luznik - Hematology 2014, the American …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies
Abstract Treatment options for newly diagnosed aplastic anemia (AA) patient includes
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
YJ Chang, Y Wang, LP Xu, XH Zhang, H Chen… - Journal of hematology & …, 2020 - Springer
Background Previous reports suggest a benefit associated with haploidentical donor
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …
Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes
Hematopoietic cell transplantation (HCT) has been successfully used to treat many
malignant and nonmalignant conditions. As supportive care, donor selection, and treatment …
malignant and nonmalignant conditions. As supportive care, donor selection, and treatment …
NK cell-based immunotherapy for hematological malignancies
S Sivori, R Meazza, C Quintarelli… - Journal of Clinical …, 2019 - mdpi.com
Natural killer (NK) lymphocytes are an integral component of the innate immune system and
represent important effector cells in cancer immunotherapy, particularly in the control of …
represent important effector cells in cancer immunotherapy, particularly in the control of …